Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

(2010) S-J Dawson et al.   BRITISH JOURNAL OF CANCER

Tissue Microarrays for Routine Diagnostic Assessment of HER2 Status in Breast Carcinoma

(2009) Primož Drev et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Analysis of Integrin  4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance

(2008) S. Lu et al.   CLINICAL CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

(2008) D. C. Allred et al.   CLINICAL CANCER RESEARCH

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

(2008) Jack Cuzick   Expert Review of Anticancer Therapy